药物对比
Canagliflozin vs Acetohexamide
Canagliflozin与Acetohexamide治疗2型糖尿病的比较。现代SGLT2抑制剂与较老的磺脲类在疗效和低血糖风险方面的对比。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating a current SGLT2 inhibitor against an older first-generation sulfonylurea for type 2 diabetes therapy.
结论
Canagliflozin is typically preferred over Acetohexamide for most patients with type 2 diabetes based on safety and extra benefits.
全部药物对比